Sign in

Private company

BELLUS Health Inc.

BELLUS Health Inc. is a pharmaceutical preparations company.1 It is headquartered in Laval, Canada.1

Last updated Oct 21, 2026.

Overview

$16.0KRevenue, fiscal 20222
-$76.1MNet income, fiscal 20222
  • IndustryPharmaceutical Preparations1
  • HeadquartersLaval, Canada1
  • Incorporated inCanada (Federal Level)3
  • Business address275 Armand-Frappier Blvd., Laval, A8 H7V 4A73
  • Filer category, Emerging growth company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-486768.8%Operating margin2
-475500.0%Net margin2
0.0%Revenue growth, 20222
-19.5%Return on equity2

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Research and development95¢$58.4M
  • Interest5¢$3.2M
  • Income tax0¢$60.0K

Out of $16.0K in revenue.2 The company lost money this year.

Financial statements

Revenue452$16.0K in 2022−41% since 2019
0$10.0K$20.0K$30.0K2019: $27.0K$27.0K20192020: $15.0K$15.0K2020−44%2021: $16.0K$16.0K2021+7%2022: $16.0K$16.0K2022+0%
Operating income452-$77.9M in 2022+203% since 2019
-$80.0M-$60.0M-$40.0M-$20.0M02019: -$25.7M-$25.7M20192020: -$32.9M-$32.9M2020+28%2021: -$73.3M-$73.3M2021+122%2022: -$77.9M-$77.9M2022+6%
Net income452-$76.1M in 2022+193% since 2019
-$80.0M-$60.0M-$40.0M-$20.0M02019: -$26.0M-$26.0M20192020: -$31.8M-$31.8M2020+22%2021: -$71.2M-$71.2M2021+124%2022: -$76.1M-$76.1M2022+7%
Fiscal year20182019202020212022
Revenue$27.0K4$15.0K5$16.0K2$16.0K2
Research and development$59.0M2$58.4M2
Operating income-$25.7M4-$32.9M5-$73.3M2-$77.9M2
Interest$55.0K2$3.2M2
Income before tax-$71.4M2-$76.0M2
Income tax-$199.0K2$60.0K2
Net income-$26.0M4-$31.8M5-$71.2M2-$76.1M2
Earnings per share-$0.545-$0.902-$0.662
Earnings per share (diluted)-$0.545-$0.902-$0.662
Shares (weighted, basic)79.3M shares2115.4M shares2

Compare BELLUS Health Inc. with another company

Corporate structure

BELLUS Health Inc. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of BELLUS Health Inc.

  • BELLUS Health Inc. Laval, Canada

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What BELLUS Health Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Operating-lease assets (leased space)$1.3M2 Dec 31, 2022$853.0K2 Dec 31, 2021+53.1%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$87.2M2 Dec 31, 2022$150.1M2 Dec 31, 2021−41.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$50.1M2 Dec 31, 2022$50.1M2 Dec 31, 20210%

Former names

  • NEUROCHEM INCAug 20, 2003 to Apr 16, 20083

Filings

100 filings to the SEC since October 2021: 2 annual reports, 23 large holders, 75 other. The latest 20:

  1. Jan 30, 2024SC 13G EDGAR
  2. Aug 14, 2023SC 13G/A EDGAR
  3. Jul 10, 202315-12G EDGAR
  4. Jun 28, 202325-NSE EDGAR
  5. Jun 28, 2023S-8 POS EDGAR
  6. Jun 28, 2023S-8 POS EDGAR
  7. Jun 28, 2023S-8 POS EDGAR
  8. Jun 28, 20236-K EDGAR
  9. Jun 28, 20236-K EDGAR
  10. Jun 16, 20236-K EDGAR
  11. Jun 6, 20236-K EDGAR
  12. Jun 2, 20236-K EDGAR
  13. May 19, 20236-K EDGAR
  14. May 16, 20236-K BELLUS HEALTH INC 6-K EDGAR
  15. May 12, 20236-K BELLUS HEALTH INC. 6-K EDGAR
  16. May 12, 20236-K EDGAR
  17. Apr 28, 20236-K REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF APRIL 2023 EDGAR
  18. Apr 28, 20236-K REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF APRIL 2023 EDGAR
  19. Apr 27, 20236-K BELLUS HEALTH INC. 6-K EDGAR
  20. Apr 27, 20236-K EDGAR

The 100 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How BELLUS Health Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARBELLUS Health Inc.1
  • CIK0001259942
  • Filer status<br>emerging growth company1
  • Incorporated inCanada (Federal Level)1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address275 Armand-Frappier Blvd., Laval, A8 H7V 4A71
  • Phone450-680-45001
  • Shares outstanding126,567,121 as of Dec 31, 20222
  • On EDGAR sinceAug 20, 20031
  • Filings495 in all: 6-K (318), SC 13D/A (30), SUPPL (28), SC 13G/A (27), SC 13G (20), F-10/A (11), 40-F (10), F-10 (9)1
    All 24 form types

    F-X (9), 40-F/A (6), S-8 POS (6), 6-K/A (3), S-8 (3), 15-12G (2), D (2), EFFECT (2), SC 13D (2), 25 (1), 25-NSE (1), 8-A12B (1), 8-A12G (1), CERT (1), D/A (1), REGDEX (1)

  • Latest filingsAnnual report (40-F) Mar 23, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18